Literature DB >> 30426500

Defining differences in patient characteristics between spasmodic dysphonia and laryngeal tremor.

Priyesh N Patel1, Edmond K Kabagambe1,2, Jennifer C Starkweather1, Matthew Keller3, Zaki A Ahmed4, Simone C Gruber4, Jordan S Akins4, C Gaelyn Garrett1, David O Francis5.   

Abstract

OBJECTIVE: To compare presenting characteristics of patients with adductor spasmodic dysphonia (ADSD), ADSD with laryngeal tremor (ADSD + LT), and laryngeal tremor without ADSD (LT).
DESIGN: Cross-sectional analysis.
METHODS: Patients treated for laryngeal movement disorders (1990-2016) were included. Analysis of variance and chi square tests measured differences in patient characteristics across the three disease groups. Using ADSD as the referent, multivariable logistic regression models were used to determine whether potential risk factors including patient demographics, family history, presence of potential inciting events prior to disease onset, and coprevalent movement disorders were associated with ADSD + LT or LT.
RESULTS: In all, 652 patients with ADSD (n = 377), ADSD + LT (n = 98), and LT (n = 177) were included. ADSD patients were significantly younger than those with ADSD + LT and LT (52.5 ± 13.4, 63.9 ± 11.3, and 69.3 ± 10.5 years, respectively; P < 0.001). Coprevalent movement disorders were more common in ADSD + LT (38.7%) and LT (57.1%) groups than in the ADSD group (11.5%; P < 0.001). Compared to ADSD, patients with ADSD + LT and LT were more likely to develop an additional movement disorder during follow-up. In multivariable analyses, increasing age, female gender, and having a movement disorder at presentation were associated with significantly greater odds of having ADSD + LT or LT when compared to ADSD.
CONCLUSION: ADSD + LT patients demonstrate intermediate gender composition and age distributions between those with ADSD and LT. These findings suggest that ADSD + LT may be a distinct phenotype in the spectrum of laryngeal movement disorders. LEVEL OF EVIDENCE: 4 Laryngoscope, 129:170-176, 2019.
© 2018 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Mesh:

Year:  2018        PMID: 30426500      PMCID: PMC6320291          DOI: 10.1002/lary.27245

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  49 in total

1.  Risk and protective factors for spasmodic dysphonia: a case-control investigation.

Authors:  Kristine Tanner; Nelson Roy; Ray M Merrill; Kamille Kimber; Cara Sauder; Daniel R Houtz; Darrin Doman; Marshall E Smith
Journal:  J Voice       Date:  2010-02-19       Impact factor: 2.009

2.  Botulinum toxin injections for essential voice tremor.

Authors:  S Hertegård; S Granqvist; P A Lindestad
Journal:  Ann Otol Rhinol Laryngol       Date:  2000-02       Impact factor: 1.547

Review 3.  Estrogen and movement disorders.

Authors:  K Kompoliti
Journal:  Clin Neuropharmacol       Date:  1999 Nov-Dec       Impact factor: 1.592

4.  Risk factors and demographics in patients with spasmodic dysphonia.

Authors:  John M Schweinfurth; Mark Billante; Mark S Courey
Journal:  Laryngoscope       Date:  2002-02       Impact factor: 3.325

Review 5.  Common movement disorders affecting the larynx: a report from the neurolaryngology committee of the AAO-HNS.

Authors:  Albert L Merati; Yolanda D Heman-Ackah; Mona Abaza; Kenneth W Altman; Lucian Sulica; Steven Belamowicz
Journal:  Otolaryngol Head Neck Surg       Date:  2005-11       Impact factor: 3.497

6.  Diagnosis and management of essential tremor and dystonic tremor.

Authors:  Alexandre Gironell; Jaime Kulisevsky
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

7.  Spasmodic dysphonia: onset, course, socioemotional effects, and treatment response.

Authors:  Kristine Tanner; Nelson Roy; Ray M Merrill; Cara Sauder; Daniel R Houtz; Marshall E Smith
Journal:  Ann Otol Rhinol Laryngol       Date:  2011-07       Impact factor: 1.547

Review 8.  Pathophysiology of dystonia.

Authors:  Marie Vidailhet; David Grabli; Emmanuel Roze
Journal:  Curr Opin Neurol       Date:  2009-08       Impact factor: 5.710

9.  Spastic dysphonia. II. Comparison with essential (voice) tremor and other neurologic and psychogenic dysphonias.

Authors:  A E Aronson; J R Brown; E M Litin; J S Pearson
Journal:  J Speech Hear Disord       Date:  1968-08

10.  Brainstem pathology in spasmodic dysphonia.

Authors:  Kristina Simonyan; Christy L Ludlow; Alexander O Vortmeyer
Journal:  Laryngoscope       Date:  2010-01       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.